As filed with the Securities and Exchange Commission on May 13, 2002
Registration No. 333-
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
--------------------------
PHOTRONICS, INC.
(Exact name of registrant as specified in its charter)
CONNECTICUT 06-0854886
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
1061 East Indiantown Road
Jupiter, Florida 33477
(561) 745-1222
(Address, including zip code, and telephone
number, including area code, of
registrant's principal executive
offices)
James A. Eder
Vice President, Secretary and General Counsel
15 Secor Road
Brookfield, Connecticut 06804
(203)740-5312
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
---------------------------------
Approximate date of commencement of proposed sale to the public: From time
to time after this registration statement becomes effective.
---------------------------------
If the only securities being registered on this form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [_]
If any of the securities being registered on this form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities being offered only in connection with dividend or
interest reinvestment plans, check the following box. [X]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the registration statement number of the earlier effective registration
statement for the same offering.[_]
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the registration
statement number of the earlier effective registration statement for the same
offering. [_]
If delivery of the prospectus is expected to be made pursuant to Rule 434
under the Securities Act, please check the following box. [_]
CALCULATION OF REGISTRATION FEE
======================================================================================================================
Proposed Maximum Proposed Maximum Amount of
Title of Each Class of Securities to Amount to be Offering Price Aggregate Offering Registration
be Registered Registered (1) Per Unit (2) Price (2) Fee
----------------------------------------------------------------------------------------------------------------------
Common stock, par value $0.01 per 1,212,218 shares $31.575 $38,275,783 $3,521.37
share
======================================================================================================================
(1) This amount represents shares to be offered by the selling shareholders from
time to time after the effective date of this Registration Statement at
prevailing market prices at time of sale. In addition to the shares set forth in
this table, the number of shares to be registered includes an indeterminable
number of shares as may become issuable as a result of stock splits, stock
dividends and similar transactions in accordance with Rule 416 of the Securities
Act of 1933, as amended.
(2) Estimated solely for the purposes of calculating the registration fee under
Rule 457 (c) based upon the average of the high and low sales prices of the
Registrant's Common Stock on May 10, 2002, as reported on the Nasdaq National
Market.
The registrant hereby amends this registration statement on such date or dates
as may be necessary to delay its effective date until the registrant shall file
a further amendment which specifically states that this registration statement
shall thereafter become effective in accordance with section 8(a) of the
securities act of 1933 or until the registration statement shall become
effective on such date as the commission, acting pursuant to said section 8(a),
may determine.
================================================================================
================================================================================
PROSPECTUS
1,212,218 Shares of Common Stock
Photronics, Inc.
Common Stock
1,212,218 shares of the common stock, $.01 par value, of Photronics,
Inc. (the "Company") are being offered by this prospectus. The shares will be
sold from time to time by the selling shareholders named in this prospectus
directly or through brokers or dealers on terms to be determined at the time of
the sale. See "Plan of Distribution" beginning on page 13. We will not receive
any of the proceeds from the sales.
Our common stock is traded on the Nasdaq National Market under the symbol
"PLAB". On May 10, 2002, the last sale price of our common stock as reported on
the Nasdaq National Market was $35.
----------
The shares of common stock offered hereby involve risks. See "Risk Factors"
beginning on page 4.
----------
The selling shareholders may be deemed to be underwriters as defined in the
Securities Act of 1933, as amended. Any profits realized by the selling
shareholders may be deemed to be underwriting commissions. If the selling
shareholders use any broker-dealers, any commissions paid to broker-dealers and,
if broker-dealers purchase any common stock as principals, any profits received
by such broker-dealers on the resale of the common stock, may be deemed to be
underwriting discounts or commissions under the Securities Act.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE
ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
----------
The date of this prospectus is May , 2002.
================================================================================
TABLE OF CONTENTS
Page
----
The Company .......................................................... 3
Risk Factors ......................................................... 4
Special Note Regarding Forward-Looking Statements .................... 11
Use of Proceeds ...................................................... 12
Selling Shareholders ................................................. 12
Plan of Distribution ................................................. 13
Legal Matters ........................................................ 15
Experts .............................................................. 15
Where You Can Find More Information .................................. 16
2
The Company
We are a leading manufacturer of photomasks, which are used primarily
by the semiconductor industry in the manufacture of integrated circuits. A
photomask is a high precision photographic quartz plate that is used as a master
to transfer microscopic circuit patterns onto semiconductor wafers during the
fabrication of integrated circuits.
We principally operated from 11 facilities at April 30, 2002, five of
which were located in the United States, three in Europe and one in each of
Korea, Singapore and Taiwan. Based upon available market information, we believe
that we have a larger share of the U. S. market for photomasks than any other
photomask manufacturer and are one of the largest photomask manufacturers in the
world.
Photomasks are a key element in the manufacture of semiconductors. They
are used to transfer integrated circuit patterns onto semiconductor wafers
during the fabrication of integrated circuits and, to a lesser extent, other
types of electronic components. Each integrated circuit consists of a series of
separate patterns, each of which is imaged onto a different photomask. The
resulting series of photomasks is then used to successively layer the circuit
patterns onto the semiconductor wafer. Both semiconductor design activity and
increases in the complexity of integrated circuits are driving the demand for
photomasks. As the complexity of integrated circuits has increased, so has the
number and complexity of photomasks used in the manufacture of a single circuit.
Photomasks are manufactured by independent manufacturers like us, and
by captive manufacturers, which are semiconductor manufacturers that produce
photomasks almost exclusively for their own use. Since the mid-1980s, there has
been a trend in the United States and Europe toward the divestiture or closing
of captive photomask operations by semiconductor manufacturers and an increase
in the share of the market served by independent manufacturers.
We sell our products primarily through a direct sales force. At April
30, 2002, we conducted our sales activities from seven sales locations in the
United States, seven in Europe, and one in each of Singapore, Korea and Taiwan.
We are a Connecticut corporation, organized in 1969. Our principal
executive offices are located at 1061 East Indiantown Road, Suite 310, Jupiter,
Florida 33477, telephone (561) 745-1222.
3
RISK FACTORS
You should carefully consider the risks described below before deciding
to invest in the common stock. The risks described below are not the only ones
facing our company. Additional risks not presently known to us or that we
currently deem immaterial may also impair our business operations.
Our business, financial condition or results of operations could be
materially adversely affected by any of these risks. The trading price of the
common stock could decline due to any of these risks, and you may lose all or
part of your investment.
This prospectus also contains forward-looking statements that involve
risks and uncertainties. Our actual results could differ materially from those
anticipated in these forward-looking statements as a result of risks,
uncertainties and other factors, including the risks faced by us described below
and elsewhere in this prospectus.
Risks Relating to Our Business
We are dependent on the semiconductor industry and the semiconductor
industry as a whole is volatile and is currently experiencing a significant
downturn.
We sell substantially all of our photomasks to semiconductor designers
and manufacturers. We believe that the demand for photomasks primarily depends
on integrated circuit design activity rather than the volume of semiconductor
sales. Consequently, an increase in semiconductor sales does not necessarily
result in a corresponding increase in photomask sales. In addition, the reduced
use of customized integrated circuits, a reduction in design complexity or other
changes in the technology or methods of manufacturing semiconductors or a
slowdown in the introduction of new semiconductor designs could reduce demand
for photomasks even if demand for semiconductors increases. Further, advances in
semiconductor and photomask design and semiconductor production methods could
reduce the demand for photomasks. Historically, the semiconductor industry has
been volatile, with sharp periodic downturns and slowdowns. These downturns have
been characterized by, among other things, diminished product demand, excess
production capacity and accelerated erosion of selling prices. The semiconductor
industry is presently in a downturn, and we expect conditions to remain weak
throughout fiscal 2002. This downturn is among the worst we have experienced and
has had a significant impact on our net sales and operating results. We cannot
assure you as to when the current downturn will end or that it will not continue
to worsen and to materially and adversely affect our business, financial
condition and operating results in the near term.
Our quarterly operating results fluctuate significantly and may
continue to do so in the future.
We have experienced fluctuations in our quarterly operating results and
we anticipate that such fluctuations will continue and could intensify in the
future. Fluctuations in operating results may result in volatility in the prices
of our common stock. Operating results may fluctuate as a result of many
factors, including size and timing of orders and shipments, loss of significant
customers, product mix, technological change, fluctuations in manufacturing
yields, competition and general economic conditions. Our customers generally
order our products on an as-needed basis, and substantially all of our net
4
sales in any quarter are dependent on orders received during that quarter. Since
we operate with little backlog and from month to month, our capital expenditures
and expense levels are based primarily on sales forecasts. Consequently, if
anticipated sales in any quarter do not occur when expected, capital
expenditures and expense levels could be disproportionately high, and our
operating results would be adversely affected. Due to the foregoing factors, we
believe that period-to-period comparisons of our operating results are not
necessarily meaningful and that these comparisons cannot be relied upon as
indicators of future performance. In addition, in future quarters our operating
results could be below the expectations of public market analysts and investors,
which, in turn, could materially adversely affect the market prices of our
common stock.
Our industry is subject to rapid technological change and we might fail
to remain competitive.
The photomask industry has been and is expected to continue to be
characterized by technological change and evolving industry standards. In order
to remain competitive, we will be required to continually anticipate, respond to
and utilize changing technologies. In particular, we believe that as
semiconductor geometries continue to become smaller, we will be required to
manufacture complex optically enhanced reticles, including optical proximity
correction and phase-shift photomasks. In addition, demand for photomasks has
been and could in the future be adversely affected by changes in methods of
semiconductor manufacturing (which could affect the type or quantity of
photomasks utilized) or increased market acceptance of alternative methods of
transferring circuit designs onto semiconductor wafers, which could reduce or
eliminate the need for photomasks. If we are unable, due to resource,
technological or other constraints, to anticipate, respond to or utilize these
or other changing technologies, our business and results of operations could be
materially adversely affected.
We may not be able to obtain a new bank facility.
As of the end of the fourth quarter of fiscal 2001, we were not in
compliance with the covenant in our revolving credit agreement that requires us
to maintain a minimum interest coverage ratio for a trailing four-quarter
period. As a result, on December 12, 2001, we repaid all outstanding loans under
the revolving credit agreement, which totaled $57.7 million, out of the proceeds
of the private placement of our 4 3/4 Convertible Subordinated Notes due 2006
and terminated the revolving credit agreement. We are seeking to replace the
revolving credit agreement with a new bank facility. However, we can give you no
assurance that we will be able to obtain a new bank facility on reasonable
terms, if at all. If we are unable to obtain a replacement bank facility or an
alternative short-term liquidity facility, our operational flexibility and short
and intermediate term liquidity may be materially adversely affected.
Our operations will continue to require significant capital, which we
may not be able to obtain.
The manufacture of photomasks requires a significant investment in
fixed assets. We expect that we will be required to continue to make significant
capital expenditures in connection with our operations. We also must make
capital expenditures in order to maintain technological leadership. Our planned
capital expenditures for fiscal 2002 are $125 million. At April 30, 2002, we had
commitments outstanding for capital expenditures of approximately $100 million.
5
There can be no assurance that we will be able to obtain the additional capital
required in connection with our operations on reasonable terms, if at all, or
that any such expenditures will not have a material adverse effect on our
business and results of operations.
We have been dependent on sales to a limited number of large customers;
the loss of any of these customers or any reduction in orders from these
customers could materially affect our sales.
Historically, we have sold a significant proportion of our products and
services to a limited number of fabricators of semiconductor products. During
fiscal 2000 and 2001, no single customer accounted for more than 10% of our
sales, but our five largest customers, in the aggregate, accounted for 36% of
our net sales in 2000 and 32% in 2001. During fiscal 1999, two customers each
accounted for approximately 10% of our net sales. None of our customers has
entered into a long-term agreement requiring it to purchase our products. The
loss of a significant customer or any reduction or delays in orders from any
significant customer, including reductions or delays due to customer departures
from recent buying patterns, or market, economic or competitive conditions in
the semiconductor industry, could adversely affect us. The ongoing consolidation
of semiconductor manufacturers may increase the likelihood and adverse effect of
losing a significant customer.
We depend on a small number of suppliers for equipment and raw
materials and, if our suppliers do not deliver their products to us, we may be
unable to deliver our products to our customers.
We rely on a limited number of photomask equipment manufacturers to
develop and supply the equipment we use. These equipment manufacturers currently
require lead times of approximately 10 to 14 months between the order and the
delivery of certain photomask imaging and inspection equipment. The failure of
such manufacturers to develop or deliver such equipment on a timely basis could
have a material adverse effect on our business and results of operations.
Further, we rely on equipment manufacturers to develop future generations of
manufacturing equipment to meet our requirements. In addition, the manufacturing
equipment necessary to produce advanced photomasks could become prohibitively
expensive.
We use high precision quartz photomask blanks, pellicles (which are
protective transparent cellulose membranes) and electronic grade chemicals in
our manufacturing processes. There are a limited number of suppliers of these
raw materials, and we have no long-term contracts for the supply of these raw
materials. Any delays or quality problems in connection with significant raw
materials, particularly photomask blanks, could cause delays in shipments of
photomasks, which could adversely affect our business and results of operations.
The fluctuation of exchange rates with respect to prices of significant raw
materials used in manufacturing also could have a material adverse effect on our
business and results of operations, although they have not been material to
date.
We face risks associated with manufacturing difficulties.
Our complex manufacturing processes require the use of expensive and
technologically sophisticated equipment and materials and are continuously
modified in an effort to improve manufacturing yields and product quality.
Minute impurities or other difficulties in the manufacturing process can lower
manufacturing yields and make products unmarketable.
6
Moreover, manufacturing leading-edge photomasks is more complex and time
consuming than manufacturing less advanced photomasks, and may lead to general
delays in the manufacturing of all levels of photomasks. We have, on occasion,
experienced manufacturing difficulties and capacity limitations that have
delayed our ability to deliver products within the time frames contracted for by
our customers. We cannot assure you that we will not experience these or other
manufacturing difficulties, or be subject to increased costs or production
capacity constraints in the future, any of which could result in a loss of
customers or could otherwise have a material adverse effect on our business and
results of operations.
We are expanding and diversifying our operations, and if we fail to
manage our expanding and more diverse operations successfully, our business and
financial results may be materially and adversely affected.
We have recently experienced rapid expansion of our operations,
primarily due to our acquisitions of existing photomask manufacturing
operations. In particular, in 2000 we completed our merger with Align-Rite
International, Inc. and acquired a majority share of PSMC, a photomask
manufacturer based in Taiwan. In August 2001, we acquired a controlling equity
interest in PKL Co., Ltd., a leading supplier of photomasks in Korea, and we
purchased the photomask manufacturing assets of Conexant Systems, Inc., a
semiconductor manufacturer based in Newport Beach, California. On April 4, 2002,
we increased our equity position in PKL to 78.8% by acquiring additional shares
of that company from several existing PKL shareholders in exchange for 1,212,218
shares of the Company's common stock. We may make additional acquisitions in the
future. In February 2002, we announced our plans to build an 18,000 square meter
facility in Shanghai, China.
This expansion has placed, and is expected to continue to place,
significant demands on our administrative, operational and financial personnel
and systems. Managing acquired operations entails numerous operational and
financial risks, including difficulties in the assimilation of acquired
operations, diversion of management's attention to other business concerns,
amortization of acquired intangible assets and potential loss of key employees
of acquired operations. Sales of acquired operations also may decline following
an acquisition, particularly if there is an overlap of customers served by us
and the acquired operation, and these customers transition to another vendor in
order to ensure a second source of supply. Furthermore, in connection with any
future acquisitions, we would be required to utilize our cash reserves and/or
issue new securities, which could have a dilutive effect on our earnings per
share, particularly during the initial integration of the acquired operations
into our operations. In addition, we have experienced in the past, and could
experience in the future, difficulties and delays in ramping up new production
facilities. If we fail to successfully manage our expanding operations, it could
have a material adverse effect on our business and results of operations.
We operate in a highly competitive industry.
The photomask industry is highly competitive, and most of our customers
utilize more than one photomask supplier. In the United States, we compete
primarily with DuPont Photomasks, Inc. and, to a lesser extent, with other
independent photomask suppliers. Internationally, our competitors include
Compugraphics, Dai Nippon Printing, DuPont Photomasks, Hoya, Taiwan Mask Corp.
and Toppan. We also compete with semiconductor manufacturers' captive photomask
manufacturing operations. We expect to face continued
7
competition from these and other suppliers in the future. Certain competitors
have substantially greater financial, technical, sales, marketing and other
resources than we do. We believe that consistency of product quality and
timeliness of delivery are the principal factors considered by customers in
selecting their photomask suppliers. Our inability to meet these requirements
could adversely affect our sales. In the past, competition led to pressure to
reduce prices which, we believe, contributed to the decrease in the number of
independent manufacturers. This pressure to reduce prices may continue in the
future.
Our substantial international operations are subject to additional
risks.
International sales, which exclude export sales, accounted for
approximately 27.5% of our net sales in fiscal 2000 and 36.0% in 2001. We
believe that maintaining significant international operations requires us to
have, among other things, a local presence in the markets in which we operate.
This requires a significant investment of financial, management, operational and
other resources. Since 1996, we have significantly expanded our operations in
international markets by acquiring existing operations in the United Kingdom,
Germany and Switzerland, establishing manufacturing operations in Singapore and
acquiring majority equity interests in photomask manufacturing operations in
Korea and Taiwan. In international markets, existing independent photomask
suppliers, including, in certain markets, DuPont Photomasks, have significant
local presences and market share.
Operations outside the United States are subject to inherent risks,
including fluctuations in exchange rates, political and economic conditions in
various countries, unexpected changes in regulatory requirements, tariffs and
other trade barriers, difficulties in staffing and managing foreign operations,
longer accounts receivable payment cycles and potentially adverse tax
consequences. These factors may have a material adverse effect on our ability to
generate sales outside the United States and, consequently, on our business and
results of operations.
Our operating results are influenced by the performance of Asian
economies.
In recent years, Asian economies have been highly volatile and
recessionary, resulting in significant fluctuations in local currencies and
other instabilities. These instabilities may continue or worsen, which could
have a material adverse impact on our financial position and results of
operations. Approximately 18.9% of our sales in fiscal 2001 were derived from
this region. We expect this percentage to be higher in fiscal 2002. Our exposure
to the business risks presented by Asian economies will increase to the extent
that we continue to expand our operations in that region.
Our business depends on management and technical personnel, who are in
great demand.
Our success, in part, depends upon key managerial, engineering and
technical personnel, as well as our ability to continue to attract and retain
additional personnel. The loss of certain key personnel could have a material
adverse effect upon our business and results of operations. There can be no
assurance that we can retain our key managerial, engineering and technical
employees or that we can attract similar additional employees in the future. We
believe that we provide competitive compensation and incentive packages to our
employees.
8
We may be unable to enforce or defend our ownership and use of
proprietary technology.
We believe that the success of our business depends more on our
proprietary technology, information and processes and know-how than on patents
or trademarks. Much of our proprietary information and technology relating to
manufacturing processes is not patented and may not be patentable. We cannot
assure you that:
. we will be able to adequately protect our technology;
. competitors will not independently develop similar technology;
or
. foreign intellectual property laws will adequately protect our
intellectual property rights.
We may become the subject of infringement claims or legal proceedings
by third parties with respect to current or future products or processes. Any
such claims or litigation, with or without merit, to enforce or protect our
intellectual property rights or to defend our company against claimed
infringement of the rights of others could result in substantial costs,
diversion of resources and product shipment delays or could force us to enter
into royalty or license agreements rather than dispute the merits of these
claims. Any of the foregoing could have a material adverse effect on our
business, results of operations and financial position.
We may be unprepared for changes to environmental laws and regulations
and we may have liabilities arising from environmental matters.
We are subject to numerous environmental laws and regulations that
impose various environmental controls on, among other things, the discharge of
pollutants into the air and water and the handling, use, storage, disposal and
clean-up of solid and hazardous wastes. Changes in these laws and regulations
may have a material adverse effect on our financial position and results of
operations. Any failure by us to adequately comply with these laws and
regulations could subject us to significant future liabilities.
In addition, these laws and regulations may impose clean-up liabilities
on current and former owners and operators of real property without regard to
fault and these liabilities may be joint and several with other parties. In the
past, we have been involved in remediation activities relating to our
properties. We believe, based upon current information, that environmental
liabilities relating to these activities or other matters will not be material
to our financial position or results of operations. However, there can be no
assurances that we will not incur any material environmental liabilities in the
future.
Our production facilities could be damaged or disrupted by a natural
disaster, labor strike, war or political unrest.
A number of our facilities are in seismically active areas. Although we
have obtained property damage and business interruption insurance, a major
catastrophe such as an earthquake or other natural disaster at any of our sites,
or political unrest, war, labor strikes or work stoppages in any of the areas
where we conduct operations, could result in a prolonged interruption of our
business. Any disruption resulting from these events could cause significant
9
delays in shipments of our products and the loss of sales and customers, and we
do not know whether our insurance would adequately compensate us for any of
these events.
Regional electric shortages may harm our operations.
Recently, California experienced an electric power supply shortage that
resulted in the intermittent loss of power in some areas in the form of rolling
blackouts. While we have not experienced any power failures to date, a blackout
could affect our ability to manufacture photomasks and meet scheduled deliveries
at this part of our network. If blackouts were to interrupt our power supply, we
would be temporarily unable to continue operations at one of our facilities. Any
such interruption in our ability to continue operations at our facilities could
damage our reputation, harming our ability to retain existing customers.
Events of September 11, 2001
Fortunately, none of our employees was lost or injured and none of our
properties or records were damaged as a result of the terrorist attacks that
occurred in the United States on September 11, 2001. Although our operations
during that week were hampered by the temporary disruption of the transportation
and communications infrastructure, the impact was not material. However, at this
time, we are unable to predict the long-term impact of these events, or of the
domestic and foreign response, on either our industry as a whole or on our
operations and financial condition in particular.
Our stock price may continue to experience large short-term
fluctuations.
In recent years, the price of our common stock has fluctuated greatly.
These price fluctuations have been rapid and severe and have left investors
little time to react. The price of our common stock may continue to fluctuate
greatly in the future due to a variety of factors, including:
. quarter to quarter variations in our operating results;
. shortfalls in our sales or earnings from levels expected by
securities analysts;
. announcements of technological innovations or new products by
us or other companies; and
. slowdowns or downturns in the semiconductor industry.
10
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Statements contained in this prospectus, including the documents that are
incorporated by reference as set forth in "Where You Can Find More Information",
that are not historical facts are "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933. Forward-looking statements
are based on management's beliefs, as well as assumptions made by and
information currently available to management. These statements involve known
and unknown risks, uncertainties, and other factors that may cause our or our
industry's results, levels of activity, performance, or achievements to be
materially different from any future results, levels of activity, performance,
or achievements expressed or implied by such forward-looking statements. Such
factors include, among others, those listed under "Risk Factors" and elsewhere
in this prospectus or the accompanying prospectus supplement. In some cases, you
can identify forward-looking statements by terminology such as "may," "will,"
"should," "intend," "expect," "plan," "anticipate," "believe," "estimate,"
"predict," "potential," or "continue" or the negative of such terms or other
comparable terminology.
Although we believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee future results, events, levels of
activity, performance, or achievements. We do not assume responsibility for the
accuracy and completeness of the forward-looking statements. We do not intend to
update any of the forward-looking statements after the date of this prospectus
to conform them to actual results.
11
USE OF PROCEEDS
We will not receive any proceeds from the sale of the shares by the
selling shareholders. The entire amount of the proceeds from the sale of the
shares of common stock will go to the selling stockholders who offer and sell
those shares.
SELLING SHAREHOLDERS
The shares of common stock covered by this prospectus were acquired by
the selling shareholders from us pursuant to a put/call option agreement dated
August 21, 2001 between each of the selling shareholders and us. We have agreed
to register shares of their common stock upon their request. The registration of
these shares of common stock does not necessarily mean that the selling
stockholders will sell all or any of the shares of common stock.
The following table sets forth information we have received as of May
10, 2002 about the number of shares of common stock beneficially owned by each
selling shareholders that may be offered using this prospectus.
Shares of Number of Shares of
Shares of Common Common Stock Registered Common Stock
Stock Beneficially For Beneficially Owned
Owned Prior to this Resale Pursuant After the Offering
Registration to this Registration (1)
Name Statement Statement
PHOTO (L) LIMITED 227,500 227,500 0
MARCH LIMITED 87,386 87,386 0
LAKEWAY LIMITED 436,932 436,932 0
MASK (L) LIMITED 460,400 460,400 0
(1) Assumes the sale of all of the shares of common stock offered by this
prospectus.
12
PLAN OF DISTRIBUTION
The sale of the shares offered by this prospectus may be made on the Nasdaq
National Market or other over the counter market at prices and at terms then
prevailing or at prices related to the then current market price or in
negotiated transactions. These shares may be sold from time to time by one or
more of the following:
.. A block trade in which the broker or dealer will attempt to sell shares as
agent but may position and resell a portion of the block as principal to
facilitate the transaction.
.. A underwritten offering on a firm commitment or best effort basis.
.. Purchases by a broker or dealer as principal and resale by a broker or
dealer for its account using this prospectus.
.. Ordinary brokerage transactions and transactions in which the broker
solicits purchasers.
.. In privately negotiated transactions directly or through a broker or dealer.
In effecting sales, brokers or dealers engaged to sell the shares may arrange
for other brokers or dealers to participate. Brokers or dealers engaged to sell
the shares will receive compensation in the form of commissions or discounts in
amounts to be negotiated immediately prior to each sale. The selling
shareholders and any brokers/dealers or agents that participate in the
distribution of common stock may be deemed to be "underwriters" within the
meaning of the Securities Act, and any profit on the sale of such securities and
any discounts, commissions, concessions, or other compensation received by any
such broker/dealer or agent may be deemed to be underwriting discounts and
commissions under the Securities Act of 1933. Each of the selling shareholders
reserves the right to accept and, together with their agents from time to time
to reject, in whole or in part, any proposed purchase of shares to be made
directly or through agents. We will receive no proceeds from any resales of the
shares offered by this prospectus, and we anticipate that the brokers or
dealers, if any, participating in the sales of the shares will receive the usual
and customary selling commissions from the selling shareholder.
A selling shareholder may enter into hedging transactions with counterparties
(including broker-dealers), and the counterparties may engage in short sales of
the common stock in the course of hedging the positions they assume with such
selling shareholder, including, without limitation, in connection with
distribution of the common stock by such counterparties. In addition, the
selling shareholders may sell short the common stock, and in such instances,
this prospectus may be delivered in connection with such short sales and the
common stock offered hereby may be used to cover such short sales. The selling
shareholders may also enter into option or other transactions with
counterparties that involve the delivery of the common stock to the
counterparties, who may then resell or otherwise transfer such common stock.
The selling shareholders may also loan or pledge the common stock and the
borrower or pledgee may sell the common stock as loaned or upon a default may
sell or otherwise transfer the pledged common stock.
13
Securities covered by this prospectus which qualify for sale pursuant to Rule
144 of the Securities Act may be sold under Rule 144 rather than pursuant to
this prospectus.
To comply with the securities laws of some states, if applicable, the shares
will be sold in these states only though brokers or dealers. In addition, in
some states, the shares may not be sold in those states unless they have been
registered or qualified for sale in these states or an exemption from
registration or qualification is available and is complied with.
Each sale may be made either at market prices prevailing at the time of such
sale, at negotiated prices, at fixed prices, which may be changed, or at prices
related to prevailing market prices.
Under the registration rights agreement that has been filed as an exhibit to the
registration statement of which this prospectus is a part, we are required to
keep this registration statement effective for one year. In addition, we and the
selling shareholders have agreed to indemnify the other against certain
liabilities, including certain liabilities under the Securities Act.
We have agreed to pay substantially all of the expenses incidental to the
registration, offering and sale of the common stock to the public other than
commissions, fees and discounts of underwriters, brokers, dealers and agents.
14
LEGAL MATTERS
The validity of the shares of common stock has been passed upon for us by James
A. Eder, our Vice President, Secretary and General Counsel. Mr. Eder
beneficially owns certain of our securities.
EXPERTS
The consolidated financial statements incorporated in this prospectus by
reference from the Photronics, Inc. Annual Report on Form 10-K for the year
ended October 31, 2001 have been audited by Deloitte & Touche LLP, independent
auditors, as stated in their report, which is incorporated herein by reference,
and has been so incorporated in reliance upon the report of such firm given upon
their authority as experts in accounting and auditing.
15
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and special reports, proxy statements and
other information with the Securities and Exchange Commission. You may read and
copy materials that we have filed with the Securities and Exchange Commission at
the following Securities and Exchange Commission public reference rooms:
450 Fifth Street, N.W. 233 Broadway 500 West Madison Street
Room 1024 New York, New York 10279 Suite 1400
Washington, D.C. 20549 Chicago, Illinois 60661
Please call the Securities and Exchange Commission at 1-800-SEC-0330
for further information on the public reference rooms.
Our common stock is quoted on the Nasdaq National Market under the
symbol "PLAB", and our Securities and Exchange Commission filings can also be
read at the following Nasdaq address:
Nasdaq Operations, 1735 K Street, N.W. Washington, D.C. 20006
Our Securities and Exchange Commission filings are also available to
the public on the Securities and Exchange Commission's Internet website at
http://www.sec.gov.
The SEC allows us to "incorporate by reference" information into this
prospectus that we have filed with it. This means that we can disclose important
information to you by referring you to another document filed separately with
the SEC. The information incorporated by reference is considered to be part of
this prospectus, except for any information that is superseded by information
that is included directly in this document or incorporated by reference in
documents subsequently filed with the SEC.
We incorporate by reference the documents listed below and any future
filings we make with the SEC under Section 13(a), 13(c), 14 or 15(d) of the
Securities Exchange Act of 1934 (i) after the date of the filing of this
registration statement and prior to its effectiveness and (ii) until all of the
common stock to which this prospectus relates have been sold or the offering is
otherwise terminated:
. Our Annual Report on Form 10-K for our fiscal year ended October 31,
2001.
. Our Report on Form 10-Q filed for the quarter ended January 31, 2002.
. Our Report on Form 8-K filed on December 13, 2001.
. Our Report on Form 8-K filed on March 11, 2002.
. Our Report on Form 8-K filed on April 4, 2002
. Our Notice of Annual Meeting and Proxy Statement dated February 20,
2002.
. The description of our common stock, par value $.01 per share,
contained in our registration statement on Form 8-A filed on March 3,
1987.
You may request a copy of these filings, at no cost, by writing to us
at the following address or telephoning us at (203) 775-9000 between the hours
of 9:00 a.m. and 4:00 p.m., Eastern Standard Time:
Photronics, Inc.
Investors Relations Department
15 Secor Road
Brookfield, CT 06804
You should rely only on the information incorporated by reference or
provided in this prospectus or any prospectus supplement. We have not authorized
anyone else to provide you with different or additional information. This
prospectus is an offer to sell or to buy only the securities referred to herein,
but only under circumstances and in jurisdictions where it is lawful to do so.
The information contained in this prospectus is current only as of the date
hereof.
16
Photronics, Inc.
1,212,218 Shares of Common Stock
----------
Prospectus
----------
May , 2002
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
The following table sets forth the costs and expenses, payable by us in
connection with the distribution of the securities being registered. All of the
amounts shown are estimates, except the Securities and Exchange Commission
registration fee.
Securities and Exchange Commission registration fee .......... $ 3,521.37
Nasdaq listing fee ........................................... $10,500
Accountant's fees and expenses ............................... $ 9,000
Legal fees and expenses ...................................... $ 2,500
----------
Total ................................................. $25,521.37
==========
ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS
Under applicable Connecticut law, the Company shall provide for
indemnification of its directors, officers, employees and agents. Applicable
Connecticut law requires the Company to indemnify a director against judgments
and other expenses of litigation when he is sued by reason of his being a
director in any proceeding brought, other than on behalf of the corporation, if
a director is successful on the merits in defense, or acted in good faith and in
a manner reasonably believed to be in the best interests of the corporation, and
in all other cases that his conduct was at least not opposed to the best
interests of the corporation, or in a criminal action or proceeding, had no
reasonable cause to believe his conduct was unlawful. In a proceeding brought on
behalf of a corporation (a derivative action), a director is entitled to be
indemnified by the corporation for reasonable expenses of litigation, if the
director is finally adjudged not to have breached his duty to the corporation.
In addition, a director is entitled to indemnification for both derivative and
non-derivative actions, if a court determines, upon application, that the
director is fairly and reasonably entitled to be indemnified. Finally, the
Company maintains director and officer liability insurance which provides
insurance for the Company's directors and officers in connection with claims
brought against them in their capacity as such with the Company.
Article Ninth of the Company's Certificate of Incorporation limits
directors' monetary liability for actions or omissions made in good faith, which
are later determined to be a breach of their duty as directors of the Company.
Article Ninth does not eliminate or limit a director's liability for breaches of
fiduciary duty for actions or omissions which (i) involved a knowing and
culpable violation of law; (ii) enabled a director or an associate to receive an
improper personal economic gain; (iii) showed a lack of good faith and conscious
disregard for his duty as a director under circumstances where the director was
aware that his actions created an unjustifiable risk of serious injury to the
Company; (iv) constituted a sustained and unexcused pattern of inattention that
amounted to an abdication of his duty; or (v) involved the improper distribution
of Company assets to its shareholders or an improper loan to an officer,
director or 5% shareholder. Article Ninth also does not preclude suits for
equitable relief, such as an injunction, nor would it shield directors from
liability for violations of the federal securities laws.
II-1
Moreover, Article Ninth does not limit the liability of directors for any act or
omission that occurred prior to the date the Article became effective and does
not limit the potential liability of officer-directors in their capacity as
officers.
II-2
ITEM 16. EXHIBITS
Exhibit
-------
4.1 Registration Rights Agreement dated April 4, 2002 between Photronics,
Inc. and Photo (L) Limited, Mask (L) Limited, Lakeway (L) Limited and
March (L) Limited.
5.1 Opinion of James A. Eder
23.1 Consent of Deloitte & Touche LLP, Independent Auditors
23.2 Consent of James A. Eder (included in Exhibit 5.1)
24.1 Power of Attorney (included on signature pages)
II-3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-3 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the Town of Brookfield, State of Connecticut, on May 13, 2002.
PHOTRONICS, INC.
By: /s/ Sean T. Smith
------------------------
SEAN T. SMITH
VICE PRESIDENT AND
CHIEF FINANCIAL OFFICER
POWER OF ATTORNEY
Each person signing below also hereby appoints Sean Smith and James A.
Eder, and each of them singly, his or her lawful attorney-in-fact with power of
substitution and re-substitution to sign in his or her name, place and stead, in
any and all capacities, to do any and all things and execute any and all
instruments as such attorney-in-fact may deem appropriate to enable Photronics,
Inc. to comply with the provisions of the Securities Act of 1933 (the
"Securities Act"), and any rules, regulations and requirements of the Securities
and Exchange Commission (the "Commission") in connection with the registration
under the Securities Act of the securities of the registrant, including
specifically, but without limiting the generality of the foregoing, the power
and authority so sign his or her name in his or her respective capacity as a
member of the Board of Directors or officer of the registrant, this registration
statement and/or such other form or forms as may be appropriate to be filed with
the Commission as any of them may deem appropriate in respect to the securities
of the registrant, to any and all amendments thereto (including post-effective
amendments) to this registration statement, to any related rule 462(b)
registration statement and to any other documents filed with the Commission, as
fully for all intents and purposes as he might or could do in person, and hereby
ratifies and confirms all said attorneys-in-fact and agents, each acting alone,
and his substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended,
this registration statement has been signed by the following persons in the
capacities and on the dates indicated.
Signature Title Date
--------- ----- ----
/s/ Daniel Del Rosario Chief Executive Officer and Director May 13, 2002
----------------------
Daniel Del Rosario
/s/ Constantine S. Macricostas Chairman of the Board and Director May 13, 2002
------------------------------
Constantine S. Macricostas
II-4
/s/ Sean T. Smith Vice President, Chief Financial Officer May 13, 2002
--------------- and principal financial and accounting
Sean T. Smith officer
/s/ Walter M. Fiederowicz Director May 13, 2002
-------------------------
Walter M. Fiederowicz
/s/ Joseph A. Fiorita, Jr. Director May 13, 2002
-------------------------
Joseph A. Fiorita, Jr.
/s/ Willem D. Maris Director May 13, 2002
-------------------
Willem D. Maris
/s/ Michael J. Yomazzo Director May 13, 2002
----------------------
Michael J. Yomazzo
II-5
EXHIBIT INDEX
Exhibit
Number Description of Exhibit
4.1 Registration Rights Agreement dated April 4, 2002 between Photronics,
Inc, and Photo (L) Limited, Mask (L) Limited, Lakeway (L) Limited and
March (L) Limited.
5.1 Opinion of James A. Eder*
23.1 Consent of Deloitte & Touche LLP*
23.2 Consent of James A. Eder (included in Exhibit 5.1)
24.1 Power of Attorney (included on signature page)
* Filed herewith